Gefitinib in Treating Patients With Malignant Mesothelioma

Clinical trial NCT00025207 · COMPLETED

Trial details

NCT number: NCT00025207
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Mesothelioma Epithelial Mesothelioma Recurrent Malignant Mesothelioma Sarcomatous Mesothelioma

Start date: 2001-09-01
Primary completion: 2006-02-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.